These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey. Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M; Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? Raposeiras-Roubín S; Abu-Assi E; Redondo-Diéguez A; González-Ferreiro R; López-López A; Bouzas-Cruz N; Castiñeira-Busto M; Peña Gil C; García-Acuña JM; González-Juanatey JR Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):585-91. PubMed ID: 25511558 [TBL] [Abstract][Full Text] [Related]
13. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K; Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298 [TBL] [Abstract][Full Text] [Related]
14. Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention. Zhong J; Chen Q; Chen L; Ye Z; Chen H; Sun J; Hong J; Ye M; Yan Y; Chen L; Luo Y BMC Cardiovasc Disord; 2020 Dec; 20(1):523. PubMed ID: 33317462 [TBL] [Abstract][Full Text] [Related]
15. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R; Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184 [TBL] [Abstract][Full Text] [Related]
16. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE). Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057 [TBL] [Abstract][Full Text] [Related]
17. In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial. Mukherjee JT; Beshansky JR; Ruthazer R; Alkofide H; Ray M; Kent D; Manning WJ; Huggins GS; Selker HP Cardiovasc Ultrasound; 2016 Aug; 14(1):29. PubMed ID: 27488569 [TBL] [Abstract][Full Text] [Related]
18. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. Biondi-Zoccai G; Sheiban I; Moretti C; Palmerini T; Marzocchi A; Capodanno D; Tamburino C; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; Pede Fd; Ramondo A; Medda M; de Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; Barlocco F; de Servi S Clin Res Cardiol; 2011 May; 100(5):403-11. PubMed ID: 21128078 [TBL] [Abstract][Full Text] [Related]